Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 5
2008 4
2009 3
2010 7
2011 5
2012 10
2013 7
2014 8
2015 7
2016 7
2017 10
2018 14
2019 10
2020 12
2021 8
2022 11
2023 6
2024 3
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events.
De Corso E, Montuori C, Pasquini E, La Mantia I, Ghidini A, Pipolo C, Garzaro M, Ottaviano G, Seccia V, Ciofalo A, Torretta S, Cantone E, Danè G, Pagella F, Lucidi D, Fadda GL, Mannocci A, Cavaliere C, Pagliuca G, Canevari FRM, Settimi S, Bussu F, Corbo M, Baroni S, Galli J; Dupilumab Italian Study Group. De Corso E, et al. Among authors: mannocci a. J Allergy Clin Immunol Pract. 2026 Feb;14(2):482-494.e13. doi: 10.1016/j.jaip.2025.10.032. Epub 2025 Oct 31. J Allergy Clin Immunol Pract. 2026. PMID: 41177433
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures.
Barbanti P, Egeo G, Pistoia F, Aurilia C, Scatena P, Rinalduzzi S, Strumia S, Salerno A, Frediani F, Galli A, Autunno M, Di Clemente L, Zucco M, Albanese M, Bono F, Bruno P, Borrello L, Messina S, Doretti A, Ranieri A, Camarda C, Vecchio R, Drago V, Fiorentini G, Tomino C, Bonassi S, Torelli P, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. Among authors: mannocci a. J Headache Pain. 2025 May 19;26(1):122. doi: 10.1186/s10194-025-02068-2. J Headache Pain. 2025. PMID: 40389834 Free PMC article.
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II).
Barbanti P, Aurilia C, Egeo G, Doretti A, d'Onofrio F, Scatena P, Rinalduzzi S, Vinciguerra L, Sansone M, Vecchio R, Drago V, Viticchi G, Bartolini M, Ranieri A, Bandettini di Poggio M, Baldisseri F, Mascarella D, Brusaferri F, Caputi L, Messina S, Autunno M, Valenza A, Orlando B, Distefano M, Borrello L, Pistoia F, Camarda C, Saporito G, Querzola G, Torelli P, Salerno A, Gragnani F, Petolicchio B, Carnevale A, Messina R, Filippi M, Tavani S, Fiorentini G, Bonassi S, Cevoli S, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. Among authors: mannocci a. J Neurol. 2025 May 7;272(6):382. doi: 10.1007/s00415-025-13095-z. J Neurol. 2025. PMID: 40332560 Free PMC article.
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study.
Barbanti P, Aurilia C, Torelli P, Egeo G, d'Onofrio F, Finocchi C, Carnevale A, Viticchi G, Russo M, Quintana S, Orlando B, Fiorentini G, Messina R, Bartolini M, Pistoia F, Filippi M, Bonassi S, Cevoli S, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. Among authors: mannocci a. J Neurol. 2025 Jan 25;272(2):170. doi: 10.1007/s00415-025-12911-w. J Neurol. 2025. PMID: 39862304 Free PMC article.
135 results